De Nicolo et al
Italy Spain Benelux Nordic Countries Rest of Europe Asia Pacific China India Japan South Korea Oceania ASEAN Countries Rest of APAC Latin America Brazil Rest of LATAM Middle East & Africa GCC Countries South Africa Israel Turkey Rest of MEA Frequently Asked Questions (FAQ) about the GLP-1 Receptor Agonist market report The market size of GLP-1 Receptor Agonist market was 15.25 billion in 2024
[22] defined the most relevant clinical and laboratory variables related to PCOS diagnosis (lipid accumulation product, abdominal circumference, age, body mass index, follicle-stimulating hormone, insulin levels, triglycerides, etc.), stratifying patients into different phenotypic clusters using ML algorithms such as RF, SVM, KNN, and the BorutaShap methods
Severe abnormalities in brainstem auditory evoked potentials [86] may also be present
206 In various brain areas, including the cerebral cortex, hippocampus, amygdala, and dorsal cochlear nucleus (DCN), the transporter is abundantly present in excitatory neurons, playing a crucial role in channeling zinc into presynaptic vesicles
